PFE 25.86

Market Overview

Market Overview PFE closed at $25.78 on December 10, 2025, reflecting a modest increase of 0.22% from the previous close. Despite a slight 30-day decline of 0.48%, the stock remains in an uptrend supported by the 20-day SMA at 25.53, 50-day SMA near 25.67, and 200-day SMA not explicitly provided but implied stable. The RSI indicates moderate momentum, with nearest support around $25.50 and resistance near $26.13. No specific upcoming events were noted, but ongoing drug approvals and clinical trial results may influence price action. Technical indicators suggest steady buyer interest and resilience in the current market environment. For information only. Last Updated 12/11/25